Advanced Member
Posted 03 March 2017 - 09:54 AM
Leading up to the study, Dr Burchert said that he and his colleagues believed that CD86-positive pDCs may be important in CML relapse because they are known to regulate T cell activation, and previous data suggest that T cells can control CML.
See CD86+ pDCs: A Marker for Treatment-free Remission in Chronic Myeloid Leukemia?
More about Treatment free remission in CML
The Leukemia & Lymphoma Society Community →
LLS Blood Cancer Discussion Boards →
Chronic Myeloid Leukemia →
News videos and articles about TFR (Treatment free remission ) in CMLStarted by survenant , 06 Nov 2015  TFR CML
|
|
|
0 members, 1 guests, 0 anonymous users
